Tiana Saak

Ms. Tiana Saak


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
TSTiana Saak
Tiana Saak
JTJeremy Paul Tervo
Jeremy Paul Tervo
BVBrandon J. Vilarello
Brandon J. Vilarello
PJPatricia T. Jacobson
Patricia T. Jacobson
FCFrancesco Caruana
Francesco Caruana
JOJonathan B. Overdevest
Jonathan B. Overdevest
Background/Objectives: Olfactory dysfunction (OD) is associated with a variety of neurologic deficits and impacts socialization decisions, mood, and overall quality of life. As a common symptom comprising the long COVID condition, persistent COVID-19-associated olfactory dysfunction (C19OD) may further impact the presentations of neuropsychiatric sequelae. Our study aims to characterize the longitudinal burden of depression, anxiety, and neuropsychiatric symptoms in a population with C19OD. Methods: Individuals with perceived C19OD completed a psychophysical screening evaluation of their sense of smell using the comprehensive Sniffin’ Sticks olfactory assessment. Only those with validated psychophysical OD were included in this prospective longitudinal study for baseline and one-year follow-up. Participants also completed PHQ-9, Beck Anxiety Inventory (BAI), and neuropsychiatric symptom questionnaires at each time point. Anxiety, depression, and neuropsychiatric symptom prevalence was calculated and compared between time points with Pearson’s chi-squared, Fisher’s exact, and Wilcoxon rank sum tests. Results: Each neuropsychiatric symptom evaluated in this study was reported by 13–49% of longitudinal cohort participants at both baseline and follow-up, except for seizure (0% at baseline and follow-up) and word-finding difficulty (61–68% at baseline and follow-up). Word-finding and focus difficulties were the most commonly reported symptoms. In total, 41% of participants reported some level of depression at baseline and 38% of participants reported depression at one-year follow-up, while 29% and 27% of participants reported some level of anxiety at respective time points. Conclusions: Individuals with C19OD are at risk for developing persistent neuropsychiatric conditions. These neurologic and psychiatric sequelae are persistent with repeated longitudinal assessment, even at nearly 2.5 years following initial COVID-19 diagnosis.

26 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
BVBrandon Jose Vilarello
Brandon Jose Vilarello
PJPatricia T. Jacobson
Patricia T. Jacobson
JTJeremy Paul Tervo
Jeremy Paul Tervo
LGLiam W. Gallagher
Liam W. Gallagher
FCFrancesco Caruana
Francesco Caruana
JOJonathan B. Overdevest
Jonathan B. Overdevest
(1) Background: Reports suggest COVID-19-associated olfactory dysfunction (OD) may result in alterations in dietary behaviors and perceived weight change, but few studies using psychophysical evaluation of post-COVID-19-associated chemosensory dysfunction and body mass index (BMI) exist. The purpose of this study is to assess the impact of both quantitative and qualitative features of COVID-19-associated OD on BMI; (2) Methods: Recruitment of thirty-one participants with self-reported OD in the form of quantitative loss with and without qualitative features. Surveys with questions specific to qualitative olfactory function, Sniffin’ Sticks tests, and BMI measures were completed at two visits, one year apart. Group differences were assessed with Wilcoxon signed-rank tests and the Holm–Bonferroni method; (3) Results: Individuals with persistent quantitative OD (n = 15) and self-reported parosmia (n = 19) showed statistically significant increases in BMI after 1 year (p = 0.004, adjusted α = 0.0125; p = 0.011, adjusted α = 0.0167). Controls with transient quantitative OD (n = 16) and participants without self-reported parosmia (n = 12) showed no statistically significant changes in BMI over the same time period (p = 0.079, adjusted α = 0.05; p = 0.028, adjusted α = 0.025); (4) Conclusions: This study shows an association between COVID-19-associated OD and BMI, suggesting olfaction may play a role in altering dietary habits and nutrition in this population. Larger study cohorts are needed to further evaluate this relationship.

Verified
Journal Article
Open access
PDF file
TSTiana Saak
Tiana Saak
JTJeremy Paul Tervo
Jeremy Paul Tervo
BMBrandon Michael Moore
Brandon Michael Moore
AWAlicia Wang
Alicia Wang
EDEmily DiMango
Emily DiMango
JOJonathan B. Overdevest
Jonathan B. Overdevest
Background/Objectives: Olfactory dysfunction (OD) is a common symptom among people with cystic fibrosis (PwCF) and contributes to environmental safety concerns, nutritional challenges, and an overall diminished quality of life. OD is perceived to progress along the lifespan in PwCF, often due to worsening sinonasal disease. Among children with cystic fibrosis (CwCF), OD is poorly characterized as limited resources and tolerance contribute to challenges in psychophysical olfactory evaluation among pediatric populations. The Children’s Personal Significance of Olfaction (ChiPSO) questionnaire was recently proposed as a tool to assess olfaction and the importance of olfactory stimulation among children. This pilot study aimed to evaluate the utility of ChiPSO among a cohort of ethnically diverse CwCF. Methods: Individuals aged 7–17 with physician-diagnosed CF were asked to complete questionnaires, including ChiPSO and the brief questionnaire on olfactory dysfunction (bQOD-NS), prior to undergoing psychophysical olfactory evaluation with the U-Sniff Identification test. Potential associations between questionnaires and olfactory performance, pulmonary function, and demographic characteristics were evaluated using Pearson and Spearman correlations, independent-sample t-tests, Wilcoxon rank sum tests, and multiple linear regression. Results: U-Sniff Identification score positively correlated with the overall ChiPSO total score [r(13) = 0.640, p = 0.010] and its environmental subdomain score [r(13) = 0.774, p < 0.001], though not with the food subdomain [r(13) = 0.450, p = 0.093], the social subdomain [r(13) = 0.343, p = 0.2], or bQOD-NS score [r(11) = −0.125, p = 0.7]. Hispanic ethnicity is associated with ChiPSO (p = 0.041). Conclusions: In this preliminary study, olfactory importance increases with olfactory function among an ethnically diverse sample of CwCF, with a preferential influence of olfactory function on personal importance of environmental olfactory information. While these results should be interpreted with limitations imposed by the pilot nature of our sample size, our pilot data highlights associations with early adolescent development of importance of olfaction that can be disrupted in the setting of progressive disease among CwCF.

25 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
TSTiana Saak
Tiana Saak
RZRenjie Zhang
Renjie Zhang
MSMatthew D.A. Spence
Matthew D.A. Spence
DDDavangere P. Devanand
Davangere P. Devanand
JOJonathan B. Overdevest
Jonathan B. Overdevest
JMJeffrey N. Motter
Jeffrey N. Motter
Background: Olfaction and memory are each independently disrupted in Alzheimer's disease (AD) early in the clinical course. Odor memory measures combining these two systems may be more capable of distinguishing these disorders than measure of either system in isolation. The purpose of this study is to evaluate psychophysical and demographic factors affecting odor memory performance and the association of odor memory performance with well‐established measures of olfaction and cognition. Method: N = 47 participants (Mean age=33.4, SD=14.6, range=19‐60, 48.9% female) with intact olfaction and cognition completed a battery of olfactory and cognitive tests. The novel odor recognition memory test (ORMT) had an encoding phase during which participants rated familiarity of ten odors, followed by a 20‐minute delayed yes/no recognition phase involving ten old and ten new odors. The discriminability index (d') was the primary outcome variable. Pearson correlations, t tests, and Wilcoxon tests were used to evaluate association with other measures and demographic variables. Result: Performance on the ORMT (d') was strongly correlated (r[45]=0.50, p <0.001) with performance on a visual recognition memory test (Rey Complex Figure Test [RCFT], d'). Importantly, ORMT performance was not significantly correlated with performance on measures of dissimilar cognitive domains, including global cognition (MoCA, r=0.05, p = 0.725), visuospatial constructional ability (RCFT Copy, r=0.11, p = 0.453), odor identification (r[45]=0.17, p = 0.266), odor discrimination (r[45]=0.23, p = 0.119), odor threshold (r[45]=0.11, p = 0.455), or Sniffin' Sticks TDI composite (r[45]=0.26, p = 0.082). Odors rated as 'familiar' during encoding were significantly more often true positives during recognition than 'unfamiliar' odors (W=825, z=‐5.12, p <0.001). Odor intensity and pleasantness ratings were not significantly associated with recognition. ORMT performance was not associated with age ( r = 0.02, p = 0.871) or sex (t[45]=0.94, p = 0.353). Conclusion: In cognitively intact individuals, the ORMT exhibited preliminary evidence of convergent validity through strong association with a well‐established visual recognition memory test and evidence of divergent validity through unrelatedness to distinct cognitive and olfactory constructs. This simple, inexpensive, well‐tolerated test represents a method of assessing recognition memory using a sensory domain less prone to interference effects. Since AD biomarkers associate with odor memory measures beyond psychophysical olfaction, ongoing studies in larger populations at‐risk for AD will determine the prognostic utility of the ORMT.

16 April 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TSTiana Saak
Tiana Saak
JTJeremy P. Tervo
Jeremy P. Tervo
PJPatricia T. Jacobson
Patricia T. Jacobson
BVBrandon J. Vilarello
Brandon J. Vilarello
FCFrancesco F. Caruana
Francesco F. Caruana
JOJonathan B. Overdevest
Jonathan B. Overdevest
Persistent COVID-19-associated olfactory dysfunction (C19OD), along with other neurologic and cognitive deficits are common features of long COVID. This study aims to evaluate longitudinal trends in neurocognitive performance within a cohort with C19OD. In individuals with perceived C19OD we performed serial psychophysical olfactory and neurocognitive assessments at baseline and follow-up one year later. At baseline evaluation, individuals with C19OD were found to have diminished cognitive functioning compared to normosmic counterparts across several domains, including attention, executive functioning, language, learning and memory, and psychomotor speed. At subsequent one-year follow-up assessment, C19OD participants demonstrated cognitive recovery, with performance comparable to normosmic counterparts. These findings suggest that early associations between C19OD and certain neurocognitive domains may dissipate upon repeated longitudinal evaluation, with partial resolution of cognitive deficits despite persistent C19OD.